Financials
- Market Capitalization 2.37 B
- Employee 357
- Founded 2009
- CEO N/A
- Website www.nurixtx.com
- Headquarter Delaware, United States
- FIGI BBG00SDJ8M78
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.03
市销率
44.74
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1865 | VCEL Vericel Corporation - Common Stock | 46.42 USD | -2.25% | -0.45% | +22.58% | +27.70% | 2.37 B USD | ||
| 1872 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 39.69 USD | -2.12% | -6.13% | +33.68% | -8.53% | 2.36 B USD | ||
| 1887 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.70 USD | +0.63% | -4.01% | +60.76% | +544.67% | 2.36 B USD | ||
| 1888 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.52 USD | 0.00% | -9.63% | +14.64% | +134.99% | 2.35 B USD |